HMB (β-Hydroxy-β-methylbutyrate)


Leucine metabolite (anti-catabolic supplement)

Beta-hydroxy-beta-methylbutyrate; a leucine metabolite that reduces muscle protein breakdown; used in catabolic states and as a supplement.

Abstract

HMB (beta-hydroxy-beta-methylbutyric acid; CAS 625-08-1; molecular formula C5H10O3; molecular weight 118.13; Ca-HMB salt CAS 135236-72-5) is a metabolite of the branched-chain amino acid leucine, produced by approximately 5 percent of leucine catabolism via alpha-ketoisocaproate. Mechanism: HMB reduces muscle protein breakdown via inhibition of the ubiquitin-proteasome pathway and enhanced cell membrane integrity; secondary effects on muscle protein synthesis through mTOR pathway activation. The clinical evidence is strongest in catabolic states (HIV wasting, cancer cachexia, sarcopenia of aging, bedrest, post-surgical recovery) where 3 g/day reduces protein breakdown and preserves lean mass. In healthy resistance-trained athletes, the effect is small. The free acid form (HMB-FA) has improved pharmacokinetics over the calcium salt (Ca-HMB) but most research uses Ca-HMB. Plasma half-life is approximately 2 hours. Used as a reference anti-catabolic supplement.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph